Back to Home
News and Media
March 31, 2021
KeifeRx Builds Leadership Team with Announcement of Chris Hoyt as Chief Executive Officer
PR Newswire
View Article
October 20, 2020
CML Drug Nilotinib Shows Early Effects in Alzheimer's Disease
Medscape Medical News
View Article
May 29, 2020
Nilotinib Appears Safe and Affects Biomarkers in Alzheimer’s Disease Clinical Trial
Georgetown University Medical Center
View Article
December 16, 2019
Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease - Audio
Jama Network
View Article
October 22, 2019
Novel agent flips on garbage disposal in neurons, eliminating toxic brain proteins in mice
Science Daily
View Article
October 8, 2019
Georgetown Offers Multiple Clinical Trials for People with Lewy Body Dementia
Georgetown University
View Article
June 4, 2019
Could a Pfizer Cancer Drug be a Treatment for a Form of Dementia? Georgetown University Launches Clinical Trial to Find Out
TrialSite News
View Article
March 13, 2019
Researchers Decode How Cancer Drug Works in Brains of Parkinson’s Disease Patients
MedStar Georgetown University Hospital
View Article
September 27, 2018
Cures Within Reach Funds Huntington’s Disease Clinical Trial with Nilotinib at Georgetown
Georgetown University
View Article
July 16, 2017
Agent Clears Toxic Proteins, Reduces Inflammation and Improves Cognition in Neurodegeneration Models
Georgetown University
View Article
March 17, 2017
Leukemia Drug Nilotinib Can Cure Parkinson's, Alzheimer's & Dementia As Well
The Science Times
View Article
March 15, 2017
Cancer Drug That Might Slow Parkinson's, Alzheimer's Headed For Bigger Tests
NPR
View Article
February 27, 2017
Georgetown Announces Phase II Clinical Trial of Nilotinib for Parkinson’s Disease
Georgetown University
View Article
January 26, 2017
Georgetown to Lead Phase 2 Study of Cancer Drug in Treating Alzheimer’s
Alzheimer's News Today
View Article
October 12, 2016
Autophagy: How “Self-Cleaning” Cells Are Key to Curing Disease
Wall Street Daily
View Article
October 10, 2016
Nobel prize - winning autophagy research laid groundwork for potential Parkinson’s treatment
The Conversation
View Article
October 4, 2016
Autophagy: Eating up Alzheimer's disease?
STAT News
View Article
October 3, 2016
Japanese scientist Yoshinori Ohsumi wins Nobel Prize in medicine for work on cellular 'recycling'
Los Angeles Times
View Article
September 29, 2016
New Clinical Trial Will Test Cancer Drug as Alzheimer’s Treatment
Alzheimer's drug discovery foundation
View Article
September 29, 2016
Georgetown receives FDA clearance to conduct clinical trial with nilotinib in Alzheimer's disease
Georgetown University
View Article
August 10, 2016
New research hints at pattern of Alzheimer's spread in the brain
The Guardian
View Article
August 1, 2016
AAIC 2016 showcases exciting Alzheimer's developments
The Pharma Letter
View Article
July 18, 2016
Cancer drug raises dopamine levels, eases Parkinson’s symptoms in early study in patients
Parkinson's News Today
View Article
July 18, 2016
Cancer drug raises dopamine levels, eases Parkinson’s symptoms in early study in patients
Parkinson's News Today
View Article
July 15, 2016
Leukemia drug may have benefits for Parkinson's disease
NeurologyAdvisor
View Article
July 15, 2016
Leukemia drug may have benefits for Parkinson's disease
NeurologyAdvisor
View Article
July 14, 2016
Cancer drug could improve Parkinson's symptoms
Drug Discovery & Development
View Article
July 14, 2016
Cancer drug could improve Parkinson's symptoms
Drug Discovery & Development
View Article
July 13, 2016
Collaboration to explore nilotinib as a potential treatment for Parkinson’s
European Pharmaceutical Review
View Article
July 13, 2016
Novartis cancer drug to be tested for Parkinson’s disease
FierceBiotech
View Article
Next
Copyright 2020 - KeifeRx
